Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Patient Care Guideline Released By Society For Vascular Nursing
The Society for Vascular Nursing (SVN) has released the first in a series of guidelines being developed that will focus on the nursing care of patients with vascular disease. Working as a collective group of experts, members of SVN have developed guidelines based on the latest available evidence supporting patient care, 2009 Clinical Practice Guideline for Patients Undergoing Endovascular Repair of Abdominal Aortic Aneurysms (AAA), which appears in the June issue of the Journal of Vascular Nursing published by Elsevier.
generic viagra online
Former Ghanaian President Named World Food Programme Ambassador
John Kofi Agyekum Kufuor, a former president of Ghana, has been named a global ambassador against hunger for the U.N."s World Food Programme (WFP), Xinhua reports. According to the news service, Kufuor will "help to underline the importance of fighting hunger on several fronts - by investing in long-term agricultural development, but also by funding WFP"s work in tackling urgent hunger needs and helping the hungry poor to access affordable and nutritious food" (Ooko, 7/20).
News of the day
Expert Statement Issued About Lantus(R) Following Recent Publications In Diabetologia
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced the release of an Expert Statement by a multidisciplinary board of renowned international experts following an in-depth assessment of the recent publications of registry analyses with Lantus(R) (insulin glargine [rDNA] injection) in Diabetologia. This board of international specialists in the field of endocrinology, oncology and epidemiology came to the conclusion, that all four manuscripts have significant methodological limitations and shortcomings, and that they provide inconsistent and inconclusive results regarding a potential link between insulin glargine use and an increased risk of cancer.
Medical Devices

New York Times Examines Debate Surrounding Use Of Experimental Treatments In Terminally Ill Patients

Some patient advocates are lobbying to legalize "compassionate use" of experimental drugs for people with terminal illnesses who have exhausted other treatments, prompting a debate about how and when to provide such patients with treatments that could prolong their lives, the New York Times reports. Most insurers do not cover unproven treatments, and physicians have concerns that using experimental treatment could give patients false hope and cause unnecessary pain. Drugmakers are concerned that if there are unfavorable outcomes from providing patients with an unproven treatment, it could hurt the drug"s chances of receiving FDA approval. At the same time, FDA does not want to grant drugs and their makers the opportunity to skip clinical trials. Currently, patients must individually apply to receive treatments through compassionate use (Harmon, New York Times, 5/17). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009